Sustained responses to lasmiditan: Results from post-hoc analyses of two Phase 3 randomized clinical trials for acute treatment of migraine

BACKGROUND: Sustained pain freedom is an important attribute of acute migraine therapies for patients and physicians. Here we report efficacy of the centrally penetrant, highly selective, 5-HT(1F) agonist lasmiditan on sustained pain freedom and other outcomes at 24 and 48 hours post-dose. STUDY DES...

Descripción completa

Detalles Bibliográficos
Autores principales: Doty, Erin Gautier, Krege, John H, Jin, Leah, Raskin, Joel, Halker Singh, Rashmi B, Kalidas, Kavita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791026/
https://www.ncbi.nlm.nih.gov/pubmed/31266353
http://dx.doi.org/10.1177/0333102419859313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791026/
https://www.ncbi.nlm.nih.gov/pubmed/31266353
http://dx.doi.org/10.1177/0333102419859313

Ejemplares similares